Assessment of Changes in Autonomy Through Analysis of Smartphone Usage Data in Patients With Alzheimer's Disease

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorPoitiers University Hospital

About this trial

Alzheimer's disease is the leading cause of dementia worldwide. The first cognitive function to be affected is memory. As the disease progresses, other cognitive systems are affected, leading to a gradual loss of independence for the patient. This loss of independence is at the heart of the psychosocial and medico-economic challenges posed by Alzheimer's disease. Functional independence refers to the patient's ability to perform activities of daily living. The evolution of autonomy varies significantly from one individual to another, and a specific, personalized assessment is necessary in order to offer appropriate care and services. There is a link between patient autonomy and psycho-behavioral disorders. Early identification of loss of autonomy in connection with psycho-behavioral disorders would allow specific treatment to be put in place.

The study hypothesis is that there is a link between changes in smartphone data and changes in the independence of patients with AD.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 60 years

Patient consulting on routine care at a memory resource and research center for Alzheimer's disease defined by cognitive memory complaints from the patient or their family and friends, evidence of impaired verbal episodic memory storage in FCSRT defined by a sum of FR values less than 17/48 and a sum of CR values less than 40/48 compared to the patient's age and socio-cultural level and no criteria on other neuropsychological tests, progressive decline over at least 6 months affecting independence, and if a brain MRI, a lumbar puncture, and/or an 18FDG PET scan were performed as part of the patient's routine care, the results must be consistent with a diagnosis of MA.

Patient with a smartphone for their exclusive use that is compatible with the installation of the IMASMART application on Android

No sensory impairment (vision or hearing impairment) that could compromise the use of a smartphone

Disqualifiers

Inability to perform the Mini-Mental State Examination or score < 17

Other neurodegenerative disorders

Severe, unstable psychiatric disorders

Terminal phase of a severe illness

Trial population

Patients receiving routine care at a memory resource and research center for Alzheimer's disease who own an Android smartphone.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Data collection

    Other intervention

    Collection of Android smartphone usage

  • Neuropsychological assesment

    Other intervention

    MMSE, FCSRT, FAB, TMT, verbal fluency test, Rey figure, BBEP, langage assesments and HAD scale

  • Autonomy questionnaire

    Other intervention

    IADL Amsterdam assessed by the caregiver

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Alzheimer's patients3 interventions

Trial outcomes

Primary outcomes

1

Comparison of changes in smartphone usage data and battery life collected at 0 and 18 months

To measure the relationship between variations in smartphone usage data-represented as a single parameter created through a mathematical combination-and variations in the Amsterdam IADL questionnaire between 0 and 18 months.

Time frame
From enrollment to the end of participation at 18 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: